지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수40
목 차표목차·············································································· ⅲ그림목차··········································································· ⅳ국문초록··········································································· ⅴⅠ. 서론··································································· 11. 연구의 필요성······················································· 12. 연구목적······························································ 43. 연구가설······························································ 44. 용어정의······························································ 5Ⅱ. 문헌고찰······························································ 81. 정보제공프로그램···················································· 82. 말기 신질환자······················································· 103. 불안·································································· 134. 자기효능감·························································· 155. 간호만족도 ···················································‥‥· 17Ⅲ. 연구방법····························································· 201. 연구설계····························································· 202. 연구대상··························································· 213. 연구도구····························································· 224. 연구진행절차························································ 245. 자료분석····························································· 316. 연구자의 윤리적 고려············································ 32Ⅳ. 연구결과···························································· 331. 대상자의 일반적 특성과 정규분포 및 동질성 검증·········· 33가. 대상자의 일반적 특성······················································· 33나. 자료의 정규분포 검증······················································ 36다. 실험군과 대조군의 동질성 검증·········································· 36라. 실험군과 대조군의 종속변수에 대한 동질성 검증······················· 362. 가설검증···························································· 38Ⅴ. 논의···································································· 42Ⅵ. 결론······································································ 50참고문헌········································································· 53Abstract···································································· 63부록·········································································· 66설문지········································································· 68
0